Intensive Glycemic Control and Skeletal Health Study

Completed · Phase 3

Conditions studied: Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease

In brief

The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.

Key facts

Study ID

NCT00324350

Run by

University of California, San Francisco

People needed

7287

Starts

2003-10-01

Expected to finish

2009-06-01

Last updated by the study team

2012-10-05

Who can join

Age: 40 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fulfills criteria for inclusion in the ACCORD main trial
• Must have been randomized into the ACCORD study and be a participant from the five CCNs in the ACCORD-BONE ancillary study.

You may not qualify if…

• Fulfills criteria for exclusion in the ACCORD main trial

Where it is running

• Berman Center for Outcomes & Clinical Research — Minneapolis, Minnesota, United States
• Wake Forest University — Winston-Salem, North Carolina, United States
• Case Western Reserve University — Cleveland, Ohio, United States
• Veterans Affairs — Memphis, Tennessee, United States
• Population Health Research Institute — Hamilton, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.